Hong_2021_Cancer.Gene.Ther_28_27

Reference

Title : LIPG: an inflammation and cancer modulator - Hong_2021_Cancer.Gene.Ther_28_27
Author(s) : Hong C , Deng R , Wang P , Lu X , Zhao X , Wang X , Cai R , Lin J
Ref : Cancer Gene Therapy , 28 :27 , 2021
Abstract :

Endothelial lipase (LIPG/EL) performs fundamental and vital roles in the human body, including cell composition, cytokine expression, and energy provision. Since LIPG predominantly functions as a phospholipase as well as presents low levels of triglyceride lipase activity, it plays an essential role in lipoprotein metabolism, and involves in the metabolic syndromes such as inflammatory response and atherosclerosis. Cytokines significantly affect LIPG expression in endothelial cells in many diseases. Recently, it is suggested that LIPG contributes to cancer initiation and progression, and LIPG attached increasing importance to its potential for future targeted therapy.

PubMedSearch : Hong_2021_Cancer.Gene.Ther_28_27
PubMedID: 32572177
Gene_locus related to this paper: human-LIPG

Related information

Gene_locus human-LIPG

Citations formats

Hong C, Deng R, Wang P, Lu X, Zhao X, Wang X, Cai R, Lin J (2021)
LIPG: an inflammation and cancer modulator
Cancer Gene Therapy 28 :27

Hong C, Deng R, Wang P, Lu X, Zhao X, Wang X, Cai R, Lin J (2021)
Cancer Gene Therapy 28 :27